Delphi has been legal advisor in connection with the listing of SpectraCure AB. First trading day was 1 July 2015. SpectraCure was formed in 2003 as a spin-off company from Lund University departments for medical laser applications and physics. The company is focused on cancer treatments with medical systems using laser light source and a photosensitizing drug, which are referred to as "Interstitial Photodynamic Therapy", PDT.

Delphi has assisted G&W Fondkommission that acted as financial advisor in the connection with the listing.

Delphi’s team consisted of Mats Dahlberg, responsible partner, assisted by Frida Lager.